Most Awaited Q3 Sale is back. Upto 30% discount on every report.
Psychedelic Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
SKU : PH4673
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
What is the Projected CAGR value of the Psychedelic Drugs Market?
Psychedelic Drugs Market is expected to grow at a CAGR of 12.6% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Psychedelic Drugs Market during 2023-2030.
Which is the fastest growing region in the Psychedelic Drugs Market?
Asia Pacific is the fastest growing market share during the forecast period.
Who are the key players in Psychedelic Drugs Market?
Key players are Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings Ltd, and GH Research PLC.
Related Reports
pharmaceuticalsPsychotherapeutic Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsPost-Traumatic Stress Disorder Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsNarcolepsy Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 15
Starting from
$4350
pharmaceuticalsOpioids Drug Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 July 28
Starting from
$4350
pharmaceuticalsAntiemetic Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 08
Starting from
$4350
pharmaceuticalsOral Thin Films Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 March 20
Starting from
$4350